Bone metastases in germ cell tumours: Lessons learnt from a large retrospective study

BJU International

Volumn 112, Issue 2, 2013, Pages 176-181

  Jamal Hanjani, Mariam ^a   Karpathakis, Anna ^a   Kwan, Amy ^b   Mazhar, Danish ^b   Ansell, Wendy ^c   Shamash, Jonathan ^c   Harper, Peter ^a   Rudman, Sarah ^a   Powles, Thomas ^c   Chowdhury, Simon ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

bone metastases; germ cell tumour; non seminoma; seminoma; testicular cancer

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CHORIONIC GONADOTROPIN BETA SUBUNIT; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADULT; ARTICLE; BONE METASTASIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAUDA EQUINA SYNDROME; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG FATALITY; FEMALE; FEMUR METASTASIS; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; NON SEMINOMATOUS GERMINOMA; OCHIDECTOMY; ORTHOPEDIC SURGERY; OVERALL SURVIVAL; PELVIS METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIBS METASTASIS; SEMINOMATOUS GERMINOMA; SOLITARY FIBROUS TUMOR; SPINAL CORD COMPRESSION; SPINE METASTASIS; SURGICAL TECHNIQUE; TESTIS CANCER; TREATMENT RESPONSE;

ADULT; BONE NEOPLASMS; HUMANS; MALE; MEDIASTINAL NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, UNKNOWN PRIMARY; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS;

EID: 84879648288     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12218     Document Type: Article

References (29)

1. Riese MJ, Vaughn DJ,. Chemotherapy for patients with poor prognosis germ cell tumors. World J Urol 2009; 27: 471-476
2. Vaughn DJ, Stadtmauer EA,. Poor-prognosis germ cell tumors: we have not yet crossed the finish line. J Clin Oncol 2007; 25: 239-240
3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594-603
4. Oechsle K, Bokemeyer C, Kollmannsberger C, et al. Bone metastases in germ cell tumor patients. J Cancer Res Clin Oncol 2012; 138: 947-952
5. Christian JA, Huddart RA, Norman A, et al. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. J Clin Oncol 2003; 21: 871-877
6. Kondagunta GV, Bacik J, Donadio A, et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005; 23: 6549-6555
7. Shamash J, Powles T, Ansell W, et al. GAMEC-a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours. Br J Cancer 2007; 97: 308-314
8. Culine S, Kramar A, Theodore C, et al. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/ doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. J Clin Oncol 2008; 26: 421-427
9. Theodore C, Chevreau C, Yataqhene Y, et al. A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors. Ann Oncol 2008; 19: 1465-1469
10. Daugaard G, Skoneczna I, Aass N, et al. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). Ann Oncol 2011; 22: 1054-1061
11. Tryakin A, Fedyanin M, Kanagavel D, et al. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study. Urology 2011; 78: 620-625
12. Bredael JJ, Vugrin D, Whitmore WF Jr,. Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 1982; 50: 548-551
13. Hitchins RN, Philip PA, Wignall B, et al. Bone disease in testicular and extragonadal germ cell tumours. Br J Cancer 1988; 58: 793-796
14. Johnson DE, Appelt G, Samuels ML, Luna M,. Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology 1976; 8: 234-239
15. Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W,. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 1997; 8: 41-47
16. Flechon A, Culine S, Theodore C, Droz JP,. Pattern of relapse after first line treatment of advanced stage germ-cell tumors. Eur Urol 2005; 48: 957-964
17. Berglund RK, Lyden SP, Tsai EC, Lieberman I, Klein EA,. Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine: part 2. Eur Urol 2006; 50: 607-608
18. Chargari C, MacDermed D, Védrine L,. Symptomatic solitary skull bone metastasis as the initial presentation of a testicular germ cell tumor. Int J Urol 2010; 17: 100
19. Benedetti G, Rastelli F, Fedele M, Castellucci P, Damiani S, Crino L,. Presentation of nonseminomatous germ cell tumor of the testis with symptomatic solitary bone metastasis. A case report with review of the literature. Tumori 2006; 92: 433-436
20. Bosco P, Bihrle W 3rd, Malone MJ, Silverman ML,. Primary skeletal metastasis of a nonseminomatous germ cell tumor. Urology 1994; 43: 564-566
21. Dixon FJ, Moore RA,. Testicular tumors; a clinicopathological study. Cancer 1953; 6: 427-454
22. Mostofi FK,. Proceedings: testicular tumors. Epidemiologic, etiologic, and pathologic features. Cancer 1973; 32: 1186-1201
23. Carver BS, Motzer RJ, Kondagunta GV, Sogani PG, Sheinfeld J,. Late relapse of testicular germ cell tumors. Urol Oncol 2005; 23: 441-445
24. Oldenburg J, Alfsen GC, Waehre H, Fossa SD,. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 2006; 94: 820-827
25. Motzer RJ, Geller NL, Tan CC, et al. Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer 1991; 67: 1305-1310
26. Grommes C, Bosl GJ, DeAngelis LM,. Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy. Cancer 2011; 117: 1911-1916
27. Bokemeyer C, Kollmannsberger C, Meisner C, et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis. J Clin Oncol 1999; 17: 3450-3456
28. Hartmann JT, Gauler T, Metzner B, et al. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. J Clin Oncol 2007; 25: 5742-5747
29. Oechsle K, Oing C, Honecker F, et al. Bone metastases in patients with relapsed/refractory germ cell tumors (GCT) undergoing first salvage chemotherapy: a retrospective analysis of a large international database. J Clin Oncol 2012; 30 (Suppl.): abstract 4597